- Home
- ATNM vs ZEO Comparison
ATNM vs ZEO Comparison
Compare ATNM & ZEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- ZEO
- Stock Information
- Founded
- ATNM 2000
- ZEO 2005
- Country
- ATNM United States
- ZEO United States
- Employees
- ATNM N/A
- ZEO N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- ZEO
- Sector
- ATNM Health Care
- ZEO
- Exchange
- ATNM Nasdaq
- ZEO NYSE
- Market Cap
- ATNM 49.0M
- ZEO 55.5M
- IPO Year
- ATNM N/A
- ZEO N/A
- Fundamental
- Price
- ATNM $1.63
- ZEO $2.47
- Analyst Decision
- ATNM Strong Buy
- ZEO
- Analyst Count
- ATNM 3
- ZEO 0
- Target Price
- ATNM $4.67
- ZEO N/A
- AVG Volume (30 Days)
- ATNM 238.4K
- ZEO 54.2K
- Earning Date
- ATNM 08-12-2025
- ZEO 08-18-2025
- Dividend Yield
- ATNM N/A
- ZEO N/A
- EPS Growth
- ATNM N/A
- ZEO N/A
- EPS
- ATNM N/A
- ZEO N/A
- Revenue
- ATNM N/A
- ZEO $61,885,622.00
- Revenue This Year
- ATNM N/A
- ZEO N/A
- Revenue Next Year
- ATNM N/A
- ZEO N/A
- P/E Ratio
- ATNM N/A
- ZEO N/A
- Revenue Growth
- ATNM N/A
- ZEO N/A
- 52 Week Low
- ATNM $1.03
- ZEO $1.05
- 52 Week High
- ATNM $7.16
- ZEO $4.00
- Technical
- Relative Strength Index (RSI)
- ATNM 50.10
- ZEO 45.89
- Support Level
- ATNM $1.54
- ZEO $2.41
- Resistance Level
- ATNM $1.89
- ZEO $2.62
- Average True Range (ATR)
- ATNM 0.13
- ZEO 0.18
- MACD
- ATNM -0.01
- ZEO -0.01
- Stochastic Oscillator
- ATNM 36.59
- ZEO 52.54
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About ZEO ZEO ENERGY CORP
Zeo Energy Corp is a vertically integrated provider of residential solar energy systems, other energy-efficient equipment, and related services currently serving customers in Florida, Texas, Arkansas, and Missouri. Its primary business activity is selling and installing residential solar energy systems that homeowners use to supplement the amount of usable electricity required to power their homes.